Me. Sullivan et al., Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction - A preliminary study, INT ANGIOL, 20(3), 2001, pp. 195-199
Background. Erectile dysfunction is associated with cardiovascular risk fac
tors (e.g. hypertension, smoking, dyslipidemia and diabetes) and is more co
mmon in patients with cardiovascular disease. We therefore assessed the pre
valence of two predictors of vascular events, fibrinogen and lipoprotein-a,
in patients with and without erectile dysfunction.
Methods. Men with erectile dysfunction (48 non-smokers 48 smokers), aged 45
-70 years, were compared with controls (21 non-smokers, 21 smokers) with no
rmal erectile function and no known pathology.
Results. Serum total cholesterol was significantly higher in non-smokers wi
th erectile dysfunction compared to both control non-smokers and erectile d
ysfunction smokers. Men with erectile dysfunction who smoked had a signific
antly higher plasma fibrinogen level than control smokers. Similarly, men w
ith erectile dysfunction, who did not smoke had higher levels of plasma fib
rinogen compared to both smokers and non-smokers without erectile dysfuncti
on. No significant difference in serum lipoprotein-a values was found.
Conclusions. These findings support the concept that cardiovascular risk fa
ctors are predictors of erectile dysfunction and that this may be another m
anifestation of vascular disease.